SCHEMBL5324879

SCHEMBL5324879

CCCCCN(NCc1ccc(OCCCN(C)C)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814478 0.89 CHRM3 (0.66) CHRM3
SCHEMBL3138470 0.88 CHRM3 (0.61) CHRM3
SCHEMBL3142620 0.88 CHRM3 (0.61) CHRM3
SCHEMBL5285760 0.85 CHRM3 (0.62) CHRM3
SCHEMBL3137874 0.84 CHRM3 (0.56) CHRM3
SCHEMBL3138322 0.83 CHRM3 (0.54) CHRM3
SCHEMBL3134489 0.82 CHRM3 (0.54) CHRM3
SCHEMBL5285440 0.82 CHRM3 (0.58) CHRM3
SCHEMBL3146872 0.81 CHRM3 (0.57) CHRM3
SCHEMBL3538495 0.80 CHRM3 (0.54) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866284-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2007-12-19 EP claimed
WO-2006099167-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO claimed